Stockreport

VBI Vaccines Reports Full Year 2023 Financial Results

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors
PDF PreHevbrio® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 234% year-over-year from 2022 to 2023Preliminary 2024 PreHevbrio U.S. sales demonstrate cont [Read more]